Over Willem Mulder
Willem Mulder is a professor of Precision Medicine at both Radboudumc / Radboud University and the TU/e Department of Biomedical Engineering. His research focuses on precision immunotherapy and innovative molecular imaging approaches.
He develops nanotechnology for immunotherapy against cancer, inflammation, infectious and cardiovascular diseases, as well as to manage organ transplantation. Through the exploration of biological, chemical, and experimental knowledge, Mulder and his teams interconnect nanotechnology, imaging, and immunology with the overarching goal of developing nanomedicine strategies for detrimental immune-mediated diseases.
Functie(s)
- Hoogleraar
Nevenfuncties
- Scientific founder, shareholder, Chief Scientific Officer (0.2 FTE), Trained Therapeutix Discovery
- Scientific founder, shareholder, BioTrip
- Founder, MulderLab BV
Nevenfuncties
- Scientific founder, shareholder, Chief Scientific Officer (0.2 FTE), Trained Therapeutix Discovery
- Scientific founder, shareholder, BioTrip
- Founder, MulderLab BV
- Co-founder and CSO, Nanoworx
- Full Professor (0.2 FTE), TU/e